Loading clinical trials...
Loading clinical trials...
A Phase 2 Multicenter, Randomized, Double-blind, Parallel-group, Active-control, Dose-ranging Study to Evaluate the Safety, Efficacy, and Comparative Systemic Bioavailability of a Single Administration of SKY0402 Via Local Infiltration for Prolonged Postoperative Analgesia in Subjects Undergoing Total Knee Arthroplasty.
Conditions
Interventions
Bupivacaine HCl
SKY0402
Locations
9
United States
West Alabama Research, Inc.
Birmingham, Alabama, United States
California Clinical Research, Inc.
Davis, California, United States
Accurate Clinical Trials, Inc.
Laguna Hills, California, United States
St. Luke's Roosevelt Hospital
New York, New York, United States
The Ohio State University Medical Center
Columbus, Ohio, United States
Texas Tech University Health Science Center
Lubbock, Texas, United States
Start Date
June 1, 2007
Primary Completion Date
August 1, 2009
Completion Date
August 1, 2009
Last Updated
June 28, 2022
NCT07547774
NCT07060495
NCT07058727
NCT07413055
NCT06862609
NCT07461467
Lead Sponsor
Pacira Pharmaceuticals, Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions